Integration of real-world evidence from different data sources in health technology assessment
J Pharm Pharm Sci. 2023 Jul 17;26:11460. doi: 10.3389/jpps.2023.11460. eCollection 2023.ABSTRACTReal-world evidence (RWE) is being increasingly used by a wide range of stakeholders involved in the therapeutic product lifecycle but remains underutilized in the health technology assessment (HTA) process. RWE aims to fill the current evidence gaps, reduce the uncertainty around the benefits of medical technologies, and better understand the long-term impact of health technologies in real-world conditions. Despite the minimal use of RWE in some elements of HTA, there has been a larger push to further utilize RWE in the HTA pro...
Source: J Pharm Pharm Sci - August 2, 2023 Category: Drugs & Pharmacology Authors: Pooyeh Graili Jason R Guertin Kelvin K W Chan Mina Tadrous Source Type: research
Integration of real-world evidence from different data sources in health technology assessment
J Pharm Pharm Sci. 2023 Jul 17;26:11460. doi: 10.3389/jpps.2023.11460. eCollection 2023.ABSTRACTReal-world evidence (RWE) is being increasingly used by a wide range of stakeholders involved in the therapeutic product lifecycle but remains underutilized in the health technology assessment (HTA) process. RWE aims to fill the current evidence gaps, reduce the uncertainty around the benefits of medical technologies, and better understand the long-term impact of health technologies in real-world conditions. Despite the minimal use of RWE in some elements of HTA, there has been a larger push to further utilize RWE in the HTA pro...
Source: J Pharm Pharm Sci - August 2, 2023 Category: Drugs & Pharmacology Authors: Pooyeh Graili Jason R Guertin Kelvin K W Chan Mina Tadrous Source Type: research
Integration of real-world evidence from different data sources in health technology assessment
J Pharm Pharm Sci. 2023 Jul 17;26:11460. doi: 10.3389/jpps.2023.11460. eCollection 2023.ABSTRACTReal-world evidence (RWE) is being increasingly used by a wide range of stakeholders involved in the therapeutic product lifecycle but remains underutilized in the health technology assessment (HTA) process. RWE aims to fill the current evidence gaps, reduce the uncertainty around the benefits of medical technologies, and better understand the long-term impact of health technologies in real-world conditions. Despite the minimal use of RWE in some elements of HTA, there has been a larger push to further utilize RWE in the HTA pro...
Source: J Pharm Pharm Sci - August 2, 2023 Category: Drugs & Pharmacology Authors: Pooyeh Graili Jason R Guertin Kelvin K W Chan Mina Tadrous Source Type: research
Integration of real-world evidence from different data sources in health technology assessment
J Pharm Pharm Sci. 2023 Jul 17;26:11460. doi: 10.3389/jpps.2023.11460. eCollection 2023.ABSTRACTReal-world evidence (RWE) is being increasingly used by a wide range of stakeholders involved in the therapeutic product lifecycle but remains underutilized in the health technology assessment (HTA) process. RWE aims to fill the current evidence gaps, reduce the uncertainty around the benefits of medical technologies, and better understand the long-term impact of health technologies in real-world conditions. Despite the minimal use of RWE in some elements of HTA, there has been a larger push to further utilize RWE in the HTA pro...
Source: J Pharm Pharm Sci - August 2, 2023 Category: Drugs & Pharmacology Authors: Pooyeh Graili Jason R Guertin Kelvin K W Chan Mina Tadrous Source Type: research
Integration of real-world evidence from different data sources in health technology assessment
J Pharm Pharm Sci. 2023 Jul 17;26:11460. doi: 10.3389/jpps.2023.11460. eCollection 2023.ABSTRACTReal-world evidence (RWE) is being increasingly used by a wide range of stakeholders involved in the therapeutic product lifecycle but remains underutilized in the health technology assessment (HTA) process. RWE aims to fill the current evidence gaps, reduce the uncertainty around the benefits of medical technologies, and better understand the long-term impact of health technologies in real-world conditions. Despite the minimal use of RWE in some elements of HTA, there has been a larger push to further utilize RWE in the HTA pro...
Source: J Pharm Pharm Sci - August 2, 2023 Category: Drugs & Pharmacology Authors: Pooyeh Graili Jason R Guertin Kelvin K W Chan Mina Tadrous Source Type: research
Integration of real-world evidence from different data sources in health technology assessment
J Pharm Pharm Sci. 2023 Jul 17;26:11460. doi: 10.3389/jpps.2023.11460. eCollection 2023.ABSTRACTReal-world evidence (RWE) is being increasingly used by a wide range of stakeholders involved in the therapeutic product lifecycle but remains underutilized in the health technology assessment (HTA) process. RWE aims to fill the current evidence gaps, reduce the uncertainty around the benefits of medical technologies, and better understand the long-term impact of health technologies in real-world conditions. Despite the minimal use of RWE in some elements of HTA, there has been a larger push to further utilize RWE in the HTA pro...
Source: J Pharm Pharm Sci - August 2, 2023 Category: Drugs & Pharmacology Authors: Pooyeh Graili Jason R Guertin Kelvin K W Chan Mina Tadrous Source Type: research
Integration of real-world evidence from different data sources in health technology assessment
J Pharm Pharm Sci. 2023 Jul 17;26:11460. doi: 10.3389/jpps.2023.11460. eCollection 2023.ABSTRACTReal-world evidence (RWE) is being increasingly used by a wide range of stakeholders involved in the therapeutic product lifecycle but remains underutilized in the health technology assessment (HTA) process. RWE aims to fill the current evidence gaps, reduce the uncertainty around the benefits of medical technologies, and better understand the long-term impact of health technologies in real-world conditions. Despite the minimal use of RWE in some elements of HTA, there has been a larger push to further utilize RWE in the HTA pro...
Source: J Pharm Pharm Sci - August 2, 2023 Category: Drugs & Pharmacology Authors: Pooyeh Graili Jason R Guertin Kelvin K W Chan Mina Tadrous Source Type: research
Integration of real-world evidence from different data sources in health technology assessment
J Pharm Pharm Sci. 2023 Jul 17;26:11460. doi: 10.3389/jpps.2023.11460. eCollection 2023.ABSTRACTReal-world evidence (RWE) is being increasingly used by a wide range of stakeholders involved in the therapeutic product lifecycle but remains underutilized in the health technology assessment (HTA) process. RWE aims to fill the current evidence gaps, reduce the uncertainty around the benefits of medical technologies, and better understand the long-term impact of health technologies in real-world conditions. Despite the minimal use of RWE in some elements of HTA, there has been a larger push to further utilize RWE in the HTA pro...
Source: J Pharm Pharm Sci - August 2, 2023 Category: Drugs & Pharmacology Authors: Pooyeh Graili Jason R Guertin Kelvin K W Chan Mina Tadrous Source Type: research
Integration of real-world evidence from different data sources in health technology assessment
J Pharm Pharm Sci. 2023 Jul 17;26:11460. doi: 10.3389/jpps.2023.11460. eCollection 2023.ABSTRACTReal-world evidence (RWE) is being increasingly used by a wide range of stakeholders involved in the therapeutic product lifecycle but remains underutilized in the health technology assessment (HTA) process. RWE aims to fill the current evidence gaps, reduce the uncertainty around the benefits of medical technologies, and better understand the long-term impact of health technologies in real-world conditions. Despite the minimal use of RWE in some elements of HTA, there has been a larger push to further utilize RWE in the HTA pro...
Source: J Pharm Pharm Sci - August 2, 2023 Category: Drugs & Pharmacology Authors: Pooyeh Graili Jason R Guertin Kelvin K W Chan Mina Tadrous Source Type: research
Integration of real-world evidence from different data sources in health technology assessment
J Pharm Pharm Sci. 2023 Jul 17;26:11460. doi: 10.3389/jpps.2023.11460. eCollection 2023.ABSTRACTReal-world evidence (RWE) is being increasingly used by a wide range of stakeholders involved in the therapeutic product lifecycle but remains underutilized in the health technology assessment (HTA) process. RWE aims to fill the current evidence gaps, reduce the uncertainty around the benefits of medical technologies, and better understand the long-term impact of health technologies in real-world conditions. Despite the minimal use of RWE in some elements of HTA, there has been a larger push to further utilize RWE in the HTA pro...
Source: J Pharm Pharm Sci - August 2, 2023 Category: Drugs & Pharmacology Authors: Pooyeh Graili Jason R Guertin Kelvin K W Chan Mina Tadrous Source Type: research
Integration of real-world evidence from different data sources in health technology assessment
J Pharm Pharm Sci. 2023 Jul 17;26:11460. doi: 10.3389/jpps.2023.11460. eCollection 2023.ABSTRACTReal-world evidence (RWE) is being increasingly used by a wide range of stakeholders involved in the therapeutic product lifecycle but remains underutilized in the health technology assessment (HTA) process. RWE aims to fill the current evidence gaps, reduce the uncertainty around the benefits of medical technologies, and better understand the long-term impact of health technologies in real-world conditions. Despite the minimal use of RWE in some elements of HTA, there has been a larger push to further utilize RWE in the HTA pro...
Source: J Pharm Pharm Sci - August 2, 2023 Category: Drugs & Pharmacology Authors: Pooyeh Graili Jason R Guertin Kelvin K W Chan Mina Tadrous Source Type: research
Integration of real-world evidence from different data sources in health technology assessment
J Pharm Pharm Sci. 2023 Jul 17;26:11460. doi: 10.3389/jpps.2023.11460. eCollection 2023.ABSTRACTReal-world evidence (RWE) is being increasingly used by a wide range of stakeholders involved in the therapeutic product lifecycle but remains underutilized in the health technology assessment (HTA) process. RWE aims to fill the current evidence gaps, reduce the uncertainty around the benefits of medical technologies, and better understand the long-term impact of health technologies in real-world conditions. Despite the minimal use of RWE in some elements of HTA, there has been a larger push to further utilize RWE in the HTA pro...
Source: J Pharm Pharm Sci - August 2, 2023 Category: Drugs & Pharmacology Authors: Pooyeh Graili Jason R Guertin Kelvin K W Chan Mina Tadrous Source Type: research
Integration of real-world evidence from different data sources in health technology assessment
J Pharm Pharm Sci. 2023 Jul 17;26:11460. doi: 10.3389/jpps.2023.11460. eCollection 2023.ABSTRACTReal-world evidence (RWE) is being increasingly used by a wide range of stakeholders involved in the therapeutic product lifecycle but remains underutilized in the health technology assessment (HTA) process. RWE aims to fill the current evidence gaps, reduce the uncertainty around the benefits of medical technologies, and better understand the long-term impact of health technologies in real-world conditions. Despite the minimal use of RWE in some elements of HTA, there has been a larger push to further utilize RWE in the HTA pro...
Source: J Pharm Pharm Sci - August 2, 2023 Category: Drugs & Pharmacology Authors: Pooyeh Graili Jason R Guertin Kelvin K W Chan Mina Tadrous Source Type: research
Integration of real-world evidence from different data sources in health technology assessment
J Pharm Pharm Sci. 2023 Jul 17;26:11460. doi: 10.3389/jpps.2023.11460. eCollection 2023.ABSTRACTReal-world evidence (RWE) is being increasingly used by a wide range of stakeholders involved in the therapeutic product lifecycle but remains underutilized in the health technology assessment (HTA) process. RWE aims to fill the current evidence gaps, reduce the uncertainty around the benefits of medical technologies, and better understand the long-term impact of health technologies in real-world conditions. Despite the minimal use of RWE in some elements of HTA, there has been a larger push to further utilize RWE in the HTA pro...
Source: J Pharm Pharm Sci - August 2, 2023 Category: Drugs & Pharmacology Authors: Pooyeh Graili Jason R Guertin Kelvin K W Chan Mina Tadrous Source Type: research
Integration of real-world evidence from different data sources in health technology assessment
J Pharm Pharm Sci. 2023 Jul 17;26:11460. doi: 10.3389/jpps.2023.11460. eCollection 2023.ABSTRACTReal-world evidence (RWE) is being increasingly used by a wide range of stakeholders involved in the therapeutic product lifecycle but remains underutilized in the health technology assessment (HTA) process. RWE aims to fill the current evidence gaps, reduce the uncertainty around the benefits of medical technologies, and better understand the long-term impact of health technologies in real-world conditions. Despite the minimal use of RWE in some elements of HTA, there has been a larger push to further utilize RWE in the HTA pro...
Source: J Pharm Pharm Sci - August 2, 2023 Category: Drugs & Pharmacology Authors: Pooyeh Graili Jason R Guertin Kelvin K W Chan Mina Tadrous Source Type: research
